Effie Skrinos

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt et al. · Proceedings of the National Academy of Sciences · 2007 · 217 citations

Life Sciences, Cancer Biology, Oncology +17

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

Andrew Weickhardt, Timothy Price, Geoff Chong et al. · Journal of Clinical Oncology · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study

Rebecca Tay, Yvonne Yeung, Fiona Chionh et al. · British Journal of Cancer · 2018 · 44 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II study of everolimus monotherapy as first-line treatment in advanced biliary tract cancer: RADichol.

Yvonne Yeung, Fiona Chionh, Timothy Price et al. · Journal of Clinical Oncology · 2014 · 16 citations

Medicine, Oncology, Pharmacology +16

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Jennifer Mooi, Fiona Chionh, Peter Savas et al. · Clinical Cancer Research · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17